by Meriem Bouslouk-Marx | 15 Jul 2020
The International Federation of Pharmaceutical Manufacturers & Associations IFPMA, the European Federation of Pharmaceutical Industries and Associations EFPIA and the German Association of Research-Based Pharmaceutical Companies vfa organised an online event to...
by Meriem Bouslouk-Marx | 1 Dec 2019
Following the invitation of Sindusfarma (Syndicate of the Pharmaceutical Products Industry in the State of São Paulo) and Anvisa (Brazilian Health Regulatory Agency), stakeholders met to discuss Brazil’s challenges with advanced therapies. The two days with...
by Meriem Bouslouk-Marx | 5 Jul 2019
Professor Sami Haddadin, Director of the Munich School of Robotics and Machine Intelligence at the Technical University of Munich, started with a historical introduction to the subject. The Dartmouth summer research project on artificial intelligence (AI) in 1956 was...
by Meriem Bouslouk-Marx | 28 May 2019
Under the patronage of René Röspel, Social Democratic Party of Germany (SPD) parliamentary group, a multi-stakeholder session on rare diseases took place at the Bundestag. This platform offered the audience a discourse with representatives from policy, patients,...
by Meriem Bouslouk-Marx | 5 Apr 2019
Appointed by the European Commission to the High-Level Expert Group on Artificial Intelligence (AI), Thomas Metzinger, Professor of Theoretical Philosophy at the Johannes Gutenberg University Mainz, gave a small foretaste of what awaits European citizens with AI. As...
by Meriem Bouslouk-Marx | 12 Mar 2019
German Ethics Council: National and international vaccination strategies Germany received global attention after increasing rates of measles, one of the most contagious diseases effectively preventable by two doses of vaccine. As part of the current debate around...